Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 6Lymphoid 3Other hematologic neoplasm 2Classical hematology 2Sarcoma 1Plasma cell 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 7Leukemia, Myelomonocytic, Chronic 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Acute 4Anemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Primary Myelofibrosis 2Polycythemia Vera 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Leukemia, Monocytic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hematologic Neoplasms 2Cytopenia 2Congenital Abnormalities 2Thrombocytosis 1Thrombocytopenia 1Thrombocythemia, Essential 1Prostatic Neoplasms 1Preleukemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, Mantle-Cell 1

Interventions

Cyclophosphamide 29fludarabine phosphate 27Mycophenolic Acid 21Peripheral Blood Stem Cell Transplantation 18Whole-Body Irradiation 17Cyclosporine 16Busulfan 15Tacrolimus 14Antilymphocyte Serum 12Melphalan 11Filgrastim 11fludarabine 10Cord Blood Stem Cell Transplantation 10Radiotherapy 7Methotrexate 7Methylprednisolone 6Etoposide 6Stem Cell Transplantation 4Cytarabine 4thymoglobulin 3Thiotepa 3Sirolimus 3Hematopoietic Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Cyclosporins 3Alemtuzumab 3ruxolitinib 2luspatercept 2Specimen Handling 2Leucovorin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Primary Myelofibrosis × Biopsy × Classical hematology × Clear all
NCT05031897 2025-10-30

Two Step Haplo With Radiation Conditioning

Thomas Jefferson University

Phase 2 Recruiting
63 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT02805868 2016-10-24

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Northwestern University

Phase EARLY_PHASE1 Withdrawn
Classical hematologyLymphoidMyeloid

Anemia, Lymphoma, Follicular, Polycythemia Vera, Thrombocytopenia, Thrombocytosis, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡